Looking to publish in Multiple Sclerosis and Related Disorders? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginMultiple Sclerosis and Related Disorders is a comprehensive journal dedicated to advancing the understanding, diagnosis and treatment of multiple sclerosis and related immune-mediated and infectious diseases of the central nervous system. Its scope includes clinical neurology, neuroepidemiology, neurobiology, neuroimaging, neuroimmunology, genetics, biomarkers, neuropsychology, neurorehabilitation, and novel therapeutics, and it welcomes Original Research, Reviews, Clinical Trials, Letters to the Editors, Editorials, and Commentaries.
Looking to publish in Multiple Sclerosis and Related Disorders? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Multiple Sclerosis and Related Disorders accepts the following article types. Click on an article type to view submission instructions.
Original Research
Reviews
Clinical Trials
Full Length Research Papers
Letters To The Editors
Recent Publications
Asymptomatic spinal cord lesions in Multiple Sclerosis: A systematic review and meta-analysis of subclinical disease activity
Mario Rotolo, Rocco Capuano, Sara Scannapieco, Annalisa Rienzo, Roberto Erro, Marianna Amboni, Maria Teresa Pellecchia, Paolo Barone, Maria Di Gregorio
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Eculizumab in AQP4-IgG–Positive Neuromyelitis Optica Spectrum Disorder
Wanfen Liu, Jiaoyang Wu, Zhuyun Liu, Hongji Lu, Qihui Wen, Jiaqing Li, Fengyan Lin
Intolerance of Uncertainty and Cyberchondria in Multiple Sclerosis: Beyond Anxiety and Depression
İrem Kübra Nur Canpolat, Okan Sokmen
Multiple sclerosis in Colombia: nationwide surveillance-based estimates and trends, 2016–2024
Carlos Alvarado-De la Hoz, Silvia Angélica Andrade-Rondon, Andrés Ricaurte-Fajardo, Jose Andrés Ordoñez-Gutierrez, Jacobo Ramirez-Triana, Andrés Felipe Cardenas-Cruz, Luis Alfonso Zarco-Montero
Differences in efficacy, safety and procedure during a continuous intrathecal baclofen trial to treat severe spasticity in Multiple Sclerosis compared to other aetiologies
Simone ME van der Gaag, Sander PG Frankema, Markus PJM Wijffels, Sara J. Baart, Eva S. van der Ploeg, Frank JPM Huygen
Frequently asked questions
How long does it take to publish?
4 days submission to first decision; 54 days submission to decision after review; 115 days submission to acceptance; 2 days acceptance to online publication.
Reformat to Multiple Sclerosis and Related Disorders using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3450 excluding taxes. Subscription publication has no open access publication fee.
Reformat to Multiple Sclerosis and Related Disorders using Livewrite Premium